[go: up one dir, main page]

SG11201406771PA - Stem cell preparations and methods of use - Google Patents

Stem cell preparations and methods of use

Info

Publication number
SG11201406771PA
SG11201406771PA SG11201406771PA SG11201406771PA SG11201406771PA SG 11201406771P A SG11201406771P A SG 11201406771PA SG 11201406771P A SG11201406771P A SG 11201406771PA SG 11201406771P A SG11201406771P A SG 11201406771PA SG 11201406771P A SG11201406771P A SG 11201406771PA
Authority
SG
Singapore
Prior art keywords
methods
stem cell
cell preparations
preparations
stem
Prior art date
Application number
SG11201406771PA
Inventor
Foteini Hassiotou
Original Assignee
Medela Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medela Holding Ag filed Critical Medela Holding Ag
Publication of SG11201406771PA publication Critical patent/SG11201406771PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
SG11201406771PA 2012-04-20 2013-04-18 Stem cell preparations and methods of use SG11201406771PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012202353A AU2012202353B2 (en) 2012-04-20 2012-04-20 Stem cell preparations and methods of use
PCT/IB2013/053061 WO2013156954A1 (en) 2012-04-20 2013-04-18 Stem cell preparations and methods of use

Publications (1)

Publication Number Publication Date
SG11201406771PA true SG11201406771PA (en) 2014-11-27

Family

ID=48577790

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406771PA SG11201406771PA (en) 2012-04-20 2013-04-18 Stem cell preparations and methods of use

Country Status (4)

Country Link
AU (2) AU2012202353B2 (en)
BR (1) BR112014026143A2 (en)
SG (1) SG11201406771PA (en)
WO (1) WO2013156954A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104845931A (en) * 2015-01-30 2015-08-19 上海坤爱生物科技有限公司 Acquisition method for human milk stem cells and construction method for human milk stem cell bank
US20210062148A1 (en) * 2019-08-26 2021-03-04 Massachusetts Institute Of Technology Breast milk derived progenitor cells and cell systems
CA3175071A1 (en) 2020-03-11 2021-09-16 Bit Bio Limited Method of generating hepatic cells
NL2027546B1 (en) * 2021-02-11 2022-09-12 Prinses Maxima Centrum Voor Kinderoncologie B V Method of producing an organoid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061695A1 (en) * 2003-12-23 2005-07-07 Carag Ag Method for isolating cells from mammary secretion

Also Published As

Publication number Publication date
AU2014202292A1 (en) 2014-05-22
BR112014026143A2 (en) 2017-06-27
AU2014202292B2 (en) 2015-07-09
AU2012202353A1 (en) 2013-11-07
AU2012202353B2 (en) 2015-01-15
WO2013156954A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
IL236672B (en) System and methods for preparation of adipose-derived stem cells
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
IL237527A0 (en) Devices and methods for culture of cells
IL241286A0 (en) Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
LT2978419T (en) Compositions for improving cell viability and methods of use thereof
ZA201408236B (en) Anti-ly6e antibodies and immunoconjugates and methods of use
GB201505771D0 (en) Protective case and methods of making
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
EP2928384A4 (en) Tissue-captured anchors and methods of use
IL233481A0 (en) Peptides and methods of using same
EP2806811A4 (en) Vertebral construct and methods of use
PL2922557T3 (en) Herbal supplements and methods of use thereof
PL2790666T3 (en) Maesa japonica extracts and methods of use
IL239043A0 (en) Thrombin solution and methods of use thereof
IL245272B (en) Pif-transfected cells and methods of use
SG11201406771PA (en) Stem cell preparations and methods of use
EP2823038A4 (en) Placental stem cells, methods for isolating same and use thereof
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
EP2841408A4 (en) Methods of maintaining and improving biological cell function and activity
IL277033A (en) Thrombin solution and methods of use thereof
AU2012901799A0 (en) Thermo-Electrochemical Cell and Method of Use
AU2012904719A0 (en) Stem cell line and use thereof
AU2012902719A0 (en) Preparations comprising adipose tissue-derived stem cells and methods of their use